This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Neurology, Other  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Stephen Knox, MD; Richard P. Atkinson, MD; Roger Stephens, MD, PhD; Robert J. Coffey, MD; Edie E. Zusman, MD

Arch Neurol. 2007;64(2):286-287.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Our first case was a 63-year-old right-handed man who required a permanent intrathecal drug infusion system for intractable nonsurgical back pain in April 2002. The catheter was placed at L1-L2 and was threaded to the T9-T10 level. The patient was successfully treated with hydromorphone and bupivacaine. Slowly escalating pain and a fall preceded a 2-week rapid deterioration in ambulation. Bowel and bladder incontinence developed. The patient had paraparesis with a sensory level at T10. Cerebrospinal fluid examination revealed a mild lymphocytic pleocytosis. Cerebrospinal fluid and catheter tip cultures revealed no growth. Magnetic resonance imaging (MRI) of the spine revealed increased signal and intramedullary enhancement at T9-T10, corresponding to the level of the catheter tip (Figure 1A). Magnetic resonance imaging 6 months later showed resolution of the changes in the . . . [Full Text of this Article]

AUTHOR INFORMATION



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Not All Intrathecal Catheter Tip MRI Findings Are Inflammatory Masses
Coffey and Allen
Anesth. Analg. 2007;104:1600-1602.
FULL TEXT